September 10th, 2020
TAILOR-PCI was a 7-year 5,300-patient clinical trial of precision medicine for cardiac stent patients, funded by Mayo Clinic and the National Institutes of Health (NIH). Spartan's FDA-cleared rapid RX CYP2C19 genotyping test was used to personalize antipl...
August 20th, 2020
If you’re reading this post, you’ve likely decided that testing for Legionella in your building is important for protecting your occupants. If you’re not aware of the dangers of Legionella bacteria, our recent blog post can give you an idea of why you sho...
August 12th, 2020
Spartan’s European Scientific Advisory Board Comments on TAILOR-PCI Results The largest genetics-based clinical trial in cardiology history supported by Spartan’s Precision Medicine technology The results of the TAILOR-PCI trial (Tailored Antiplatelet I...
August 7th, 2020
After seven years and 5,300-patients tested, the results of the landmark TAILOR-PCI trial were announced in a virtual ACC session. This trial investigated whether a prospective approach using rapid on-site CYP2C19 testing could improve patient outcomes wh...
July 8th, 2020
The CDC chose Spartan Bioscience, an Ottawa-based biotechnology company, to assist with a Legionnaires’ outbreak in Chesterfield, VA. The Virginia Department of Health (VDH) identified an increase in Legionnaires’ disease cases in Chesterfield County and...
May 4th, 2020
Has your building shut down or reduced operations due to COVID-19? If so, you may be putting your employees or building occupants in danger, especially if your water system has been stagnant, or has had low flow during the shutdown. With the recent outbr...
March 26th, 2020
For those who don’t come from a medical background, reading scientific articles can be intimidating. For example, the American College of Cardiology (ACC) website recently featured a clinical trial using my company’s technology and the article used words...
